Bristol-Myers Squibb, BioMotiv launch new biotechnology firm Anteros Pharmaceuticals

Anteros Pharmaceuticals will develop a new class of drugs for fibrotic and other inflammatory diseases (Credit: moritz320 from Pixabay)